Discover open access scientific publications

Search, annotate, share and cite publications

Publications by M. Teresa Cedena

Correction: Mutations in the DNA Methylation Pathway and Number of Driver Mutations Predict Response to Azacitidine in Myelodysplastic Syndromes

English

Related publications

Mutations and Karyotype Predict Treatment Response in Myelodysplastic Syndromes

American Journal of Hematology

English

Role of BCL2L10 Methylation and TET2 Mutations in Higher Risk Myelodysplastic Syndromes Treated With 5-Azacytidine

Cancer Research

English

IDH1 and IDH2 Mutations in Myelodysplastic Syndromes and Role in Disease Progression

Cancer Research

English

Prognostic Significance of U2AF1 Mutations in Myelodysplastic Syndromes: A Meta-Analysis

Journal of International Medical Research

English

A Calcium- And Calpain-Dependent Pathway Determines the Response to Lenalidomide in Myelodysplastic Syndromes

Nature Medicine

Molecular Biology

English

Epigenetic Approaches in the Treatment of Myelodysplastic Syndromes: Clinical Utility of Azacitidine

OncoTargets and Therapy

English

Driver Mutations in Melanoma

Libri Oncologici

English

BRD4 Inhibition Enhances Azacitidine Efficacy in Acute Myeloid Leukemia and Myelodysplastic Syndromes

Frontiers in Oncology

Cancer Research

English

Somatic Driver Mutations in Melanoma

Cancer Research

English